Lake Street Advisors Group LLC bought a new stake in Danaher Co. (NYSE:DHR) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 8,317 shares of the conglomerate’s stock, valued at approximately $772,000.
A number of other institutional investors have also added to or reduced their stakes in the business. MetLife Investment Advisors LLC bought a new stake in shares of Danaher during the fourth quarter worth about $17,580,000. Gotham Asset Management LLC grew its holdings in shares of Danaher by 375.6% during the fourth quarter. Gotham Asset Management LLC now owns 127,041 shares of the conglomerate’s stock worth $11,792,000 after purchasing an additional 100,331 shares during the last quarter. Maple Capital Management Inc. grew its holdings in shares of Danaher by 96.0% during the fourth quarter. Maple Capital Management Inc. now owns 21,200 shares of the conglomerate’s stock worth $1,968,000 after purchasing an additional 10,385 shares during the last quarter. Laurel Wealth Advisors Inc. bought a new stake in shares of Danaher during the fourth quarter worth about $206,000. Finally, M Holdings Securities Inc. grew its holdings in shares of Danaher by 19.7% during the fourth quarter. M Holdings Securities Inc. now owns 8,465 shares of the conglomerate’s stock worth $2,373,000 after purchasing an additional 1,393 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.
Danaher Co. (DHR) opened at $100.31 on Tuesday. Danaher Co. has a 12 month low of $78.97 and a 12 month high of $104.82. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $71,103.26, a P/E ratio of 28.42, a price-to-earnings-growth ratio of 2.14 and a beta of 1.03.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The firm had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. During the same period in the previous year, the firm earned $1.05 earnings per share. The company’s revenue was up 10.9% compared to the same quarter last year. equities research analysts anticipate that Danaher Co. will post 4.37 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, March 29th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a yield of 0.64%. Danaher’s payout ratio is 15.86%.
In other Danaher news, CFO Daniel L. Comas sold 62,989 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $101.96, for a total value of $6,422,358.44. Following the transaction, the chief financial officer now directly owns 227,805 shares of the company’s stock, valued at $23,226,997.80. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Angela S. Lalor sold 42,988 shares of the business’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $102.29, for a total value of $4,397,242.52. Following the completion of the transaction, the senior vice president now directly owns 82,008 shares in the company, valued at $8,388,598.32. The disclosure for this sale can be found here. Over the last three months, insiders sold 313,260 shares of company stock worth $31,657,786. Insiders own 12.20% of the company’s stock.
Several analysts have recently weighed in on the company. Credit Suisse Group restated an “outperform” rating on shares of Danaher in a report on Friday, March 9th. Cowen restated a “buy” rating and set a $110.00 price target on shares of Danaher in a report on Tuesday, January 30th. Royal Bank of Canada restated a “hold” rating and set a $98.00 price target on shares of Danaher in a report on Wednesday, January 31st. Stifel Nicolaus upped their target price on Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. Finally, Morgan Stanley upped their target price on Danaher from $103.00 to $110.00 and gave the company an “overweight” rating in a report on Wednesday, January 31st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $101.40.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.